ArticleScientific reports2026
A lysine-free REC tag system for proximity-biotinylation applications.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Protein-protein interaction analysis requires not only the detection of a single protein but also multiple interacting proteins. The proximity-dependent biotin identification (BioID) method using biotin proximity-labelled enzymes is a protein-protein interaction method used in cells and in vivo; however, the detection tags are limited because even the lysine residues of the amino acids in the detection tag are labelled by the enzyme. Herein, we demonstrated a new affinity tag system without lysine residues suitable for use in the BioID method. After immunisation of rabbits with Plasmodium falciparum PfRipr5 protein, 22 anti-PfRipr5 monoclonal antibodies were isolated by ImmunoSpot Array Assay on a Chip, and their binding and specificity were analysed. The results showed that No. 6 anti-PfRipr5 monoclonal antibody had the highest sensitivity and specificity. The epitope was identified to contain one lysine residue; therefore, the mutated epitope, which was replaced with an arginine residue, showed similar binding properties. It was named REC tag for further analysis, and the REC tag was compatible with IB, AlphaScreen, and immunostaining and showed resistance to biotinylation using TurboID in vitro. These results indicate that a new detection tag system could be developed, in which REC tags could be used to detect BioID methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.